Acorda

United Spinal Association's 2nd Annual Disability Leadership & Policy Summit: Health Issues and People with Disabilities

... free event, hosted by United Spinal Association, Nassau County Office for the Physically Challenged, Hofstra University and NSCIA, and sponsored by acorda Therapeutics. United Spinal will honor Don Dryer, Executive Director of The Nassau County Office of the Physically Challenged and Hofstra will ...

Minnesota partnership advances potential MS therapy

...sity of Minnesota. The therapy is under license to acorda Therapeutics, Inc. (NASDAQ: ACOR), which is suppor...ple with multiple sclerosis, says Ron Cohen, M.D., acorda president and CEO. The Partnership has provided a ...velopment was also performed in collaboration with acorda Therapeutics. The Partnership facility subsequentl...

What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17

...rst Harris Interactive Poll ever to survey people with MS and their care partners about mobility issues. The initiative was done in collaboration with acorda Therapeutics. An in-depth media briefing on the survey's findings will follow on April 8 in New York. Advocacy Action Alert -- A cross-organizat...

Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance

...Clinical Research Associate. Prior to joining Kendle, Mr. Kenny served as a Clinical Research Associate for several pharmaceutical companies including acorda Therapeutics, Elan Pharmaceutical Research Corporation and Sandoz Pharmaceutical. "We are pleased to welcome Mr. Kenny to Catalyst at such an import...

Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc.

... companies such as StressGen Biotechnologies Corporation (now Nventa Biopharmaceuticals Corporation), ID Biomedical Corp., Salix Pharmaceuticals Inc., acorda Therapeutics Inc., Inex Pharmaceuticals Corporation, Nortran Pharmaceuticals Corp. (now Cardiome Pharma Corp.) and BioMS Medical Corp. Mr. Meekison ha...

Acorda in Medical Technology

Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data Selected for Scientific Highlights Program at the American Academy of Neurology Meeting

...use actual results to differ materially, including acorda Therapeutics' ability to successfully market and s...lings with the Securities and Exchange Commission. acorda Therapeutics may not actually achieve the goals or...g after the date of this press release. About acorda Therapeutics ...

Acorda Therapeutics to Host Analyst and Investor Reception

...use actual results to differ materially, including acorda Therapeutics' ability to successfully market and s...lings with the Securities and Exchange Commission. acorda Therapeutics may not actually achieve the goals or...ring after the date of this press release. About acorda Therapeutics ...

Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting

... BOSTON--(BUSINESS WIRE)--May 2, 2007 - acorda Therapeutics, Inc.(R) (Nasdaq: ACOR) today present...gnals to pass through areas of damage. Webcast acorda will hold a webcast this evening at 7 p.m. Eastern...e. Study data will be presented and members of the acorda management team will be available for a question a...

Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting

...use actual results to differ materially, including acorda Therapeutics' ability to successfully market and s...lings with the Securities and Exchange Commission. acorda Therapeutics may not actually achieve the goals or...ring after the date of this press release. About acorda Therapeutics ...

Acorda in Biological News

Acorda Therapeutics submits new drug application for Fampridine-SR in multiple sclerosis

... HAWTHORNE, N.Y., February 2, 2009 acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced ...ion. "This NDA filing is a major milestone for acorda and our Fampridine-SR development program," said acorda Therapeutics President and CEO Ron Cohen, M.D. "Wa...

Acorda in Biological Technology

I Walk Because Program Gives Consumers a Voice

...sis, Saatchi & Saatchi Wellness partnered with acorda Therapeutics to relaunch the online component of t...aid Erica Wishner, Director of Consumer Marketing, acorda Therapeutics. "We received really positive feedba...anted to share their personal stories. About acorda Therapeutics ...

Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer

...last ten years, Mr. Phillips has held board positions for a number of public and private life sciences companies and currently serves as a director of acorda Therapeutics, Inc., a publicly traded biopharmaceutical company. Mr. Phillips received a B.A. in economics from the University of Colorado in Boulder....

Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team

...siness school as a Merck fellow. He currently serves on the boards of Oscient Pharmaceuticals and MonoSol Rx, and had been an observer on the board of acorda Therapeutics. Dr. Brown holds an A.B. from Yale College, an M.D. from S.U.N.Y. Upstate Medical Center, and an M.B.A. from Harvard Business School. Al...